The decision to initiate pharmacotherapy requires shared decision-making, discussing realistic expectations, potential adverse effects, cost considerations, and the likely need for indefinite treatment duration
Medications can stay in your body for a variable amount of time, and the plasma you donate may be used in critical treatments for patients with specific health conditions
5- other GLP-1 trials in Parkinsons have been statistically negative or the results unclear, 6- the study was conducted in only very early Parkinsons cases, 7- the data, if replicable, may not be generalizable to all GLP-1 agonist drugs or to all subtypes of Parkinsons, and 8- the drug Lixisenatide requires a DAILY injection
Moreover, many patients describe a life-changing decrease in food cravings and obsessions, liberating them to enjoy other aspects of life
For athletes, fitness enthusiasts, or individuals recovering from injury, the choice between TB-500 and BPC-157 depends on the specific healing goals: Choose TB-500 if systemic tissue regeneration, muscle growth, and vascular support are priorities